Mark Diker, Cantel Medical Corp. (CMD)’s insider Sold 5,000 Shares; Last Week Sociedad Química y Minera de Chile S.A. (SQM) Coverage

The director of Cantel Medical Corp and corporation’s insider Mark Diker unloaded 5,000 shares of the ‘s company based on the average share price which is $111.8 of a share. These transaction’s shares had a value of approximately $558,847 USD. The probability of this deal remaining hidden is nil, with the director right now having ownership of 471,122 shares – that is 1.12% of the market capitalization of the company. The public filing was unveiled on 17/01/2018 with the SEC and is now available for free here.

Among 8 analysts covering Sociedad Quimica y Minera de Chile (NYSE:SQM), 2 have Buy rating, 1 Sell and 5 Hold. Therefore 25% are positive. Sociedad Quimica y Minera de Chile had 24 analyst reports since August 28, 2015 according to SRatingsIntel. The stock of Sociedad Química y Minera de Chile S.A. (NYSE:SQM) earned “Hold” rating by BMO Capital Markets on Tuesday, October 24. The firm earned “Sell” rating on Wednesday, July 13 by Citigroup. The company was maintained on Tuesday, December 19 by Scotia Capital. The company was maintained on Thursday, August 24 by BMO Capital Markets. The stock of Sociedad Química y Minera de Chile S.A. (NYSE:SQM) earned “Neutral” rating by Citigroup on Wednesday, January 25. The firm earned “Hold” rating on Thursday, October 5 by BMO Capital Markets. The stock of Sociedad Química y Minera de Chile S.A. (NYSE:SQM) has “Hold” rating given on Tuesday, December 8 by Santander. The rating was upgraded by HSBC to “Buy” on Wednesday, October 19. The rating was downgraded by JP Morgan to “Neutral” on Wednesday, September 30. As per Tuesday, August 29, the company rating was maintained by BMO Capital Markets. See Sociedad Química y Minera de Chile S.A. (NYSE:SQM) latest ratings:

18/01/2018 Broker: Deutsche Bank Old Rating: Hold New Rating: Buy Upgrade
18/01/2018 Broker: Scotia Capital Rating: Hold New Target: $60.0 Maintain
19/12/2017 Broker: Scotia Capital Rating: Hold New Target: $50.0 Maintain
24/10/2017 Broker: BMO Capital Markets Rating: Hold New Target: $60.0 Maintain
11/10/2017 Broker: HSBC Old Rating: Buy New Rating: Reduce Downgrade
05/10/2017 Broker: BMO Capital Markets Rating: Hold New Target: $50.0 Maintain
13/09/2017 Broker: Bank of America Old Rating: Neutral New Rating: Buy Upgrade
29/08/2017 Broker: BMO Capital Markets Rating: Market Perform Old Target: $35 New Target: $45 Maintain
24/08/2017 Broker: BMO Capital Markets Rating: Hold New Target: $35.0 Maintain

The stock decreased 3.54% or $2.09 during the last trading session, reaching $56.93. About 2.53M shares traded or 102.23% up from the average. Sociedad Química y Minera de Chile S.A. (NYSE:SQM) has risen 69.80% since January 19, 2017 and is uptrending. It has outperformed by 53.10% the S&P500.

Chemical and Mining Company of Chile Inc. produces and sells specialty plant nutrients, industrial chemicals, iodine and derivatives, lithium and derivatives, potassium, and other services and products. The company has market cap of $14.98 billion. The firm offers specialty plant nutrients, such as potassium nitrate, sodium nitrate, sodium potassium nitrate, specialty blends, and other specialty fertilizers for crops, including vegetables, fruits, and flowers under the Ultrasol, Qrop, Speedfol, and Allganic brands. It has a 37.65 P/E ratio. It also provides iodine and its derivatives for use in medical, pharmaceutical, agricultural, and industrial applications comprising X-ray contrast media, polarizing films for LCD and LED, antiseptics, biocides and disinfectants in the synthesis of pharmaceuticals, electronics, pigments, and dye components under the QIodine brand.

The stock increased 1.80% or $2 during the last trading session, reaching $113.1. About 116,756 shares traded. Cantel Medical Corp. (NYSE:CMD) has risen 11.32% since January 19, 2017 and is uptrending. It has underperformed by 5.38% the S&P500.

Analysts await Cantel Medical Corp. (NYSE:CMD) to report earnings on March, 8. They expect $0.58 earnings per share, up 11.54% or $0.06 from last year’s $0.52 per share. CMD’s profit will be $24.32 million for 48.75 P/E if the $0.58 EPS becomes a reality. After $0.57 actual earnings per share reported by Cantel Medical Corp. for the previous quarter, Wall Street now forecasts 1.75% EPS growth.

Cantel Medical Corp. provides infection prevention services and products for the healthcare market worldwide. The company has market cap of $4.74 billion. The firm operates through four divisions: Endoscopy, Water Purification and Filtration, Healthcare Disposables, and Dialysis. It has a 62.52 P/E ratio. The Endoscopy segment offers automated endoscope reprocessing systems; detergents; leak testing and manual cleaning products; storage cabinets; transport systems; mobile medical carts; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid and flexible endoscopes, and other instrumentation; cleaning and disinfecting reusable components used in gastrointestinal endoscopy procedures; and technical maintenance services.

Investors sentiment decreased to 1.02 in Q3 2017. Its down 0.39, from 1.41 in 2017Q2. It dropped, as 16 investors sold Cantel Medical Corp. shares while 73 reduced holdings. 36 funds opened positions while 55 raised stakes. 35.03 million shares or 0.40% less from 35.18 million shares in 2017Q2 were reported. Fred Alger accumulated 0.18% or 418,195 shares. The New Jersey-based Bessemer has invested 0% in Cantel Medical Corp. (NYSE:CMD). Piermont Mngmt reported 0.34% stake. Schwab Charles Inv Mgmt holds 0.02% or 198,741 shares. Raymond James reported 2,591 shares. 22,379 are owned by Pub Sector Pension Investment Board. Zurcher Kantonalbank (Zurich Cantonalbank) invested in 0% or 4,317 shares. Brown Cap Management Ltd Llc holds 4.39% or 3.83 million shares in its portfolio. State Of Alaska Department Of Revenue invested 0.03% in Cantel Medical Corp. (NYSE:CMD). California Public Employees Retirement Systems holds 0.01% of its portfolio in Cantel Medical Corp. (NYSE:CMD) for 70,052 shares. 32,660 were accumulated by Deutsche Natl Bank Ag. Metropolitan Life Insur Company Ny holds 0.01% or 24,379 shares in its portfolio. Riverhead Capital Mngmt Ltd has 3,187 shares. Profund Limited Company stated it has 4,342 shares or 0.02% of all its holdings. Jefferies Group Incorporated Ltd Company stated it has 0.01% of its portfolio in Cantel Medical Corp. (NYSE:CMD).